Our in vivo data also indicated that delivery of an adenovirus-mediated Yy1 shRNA vector under the control of the surfactant protein C promoter protected mice from PS-NPs-induced pulmonary fibrosis. The gene discussed is SFTPC; the disease is pulmonary fibrosis.